Home Title Index Topic Index Sources Directory News Releases Sources Calendar

Drug Candidates
AlterLinks Topic Index

  1. Anavex appoints contract research organizations to initiate Phase I/IIa clinical programs, regulatory strategies in Alzheimer's disease
    Sources News Release
    Resource Type: Article
    Published: 2010
    Anavex Life Sciences Corp signs a definitive master services agreement with Genesis BioPharma Group and ABX-CRO Advanced Pharmaceutical Services to begin clinical studies and regulatory filings for its lead compound for the treatment of Alzheimer#s.
  2. Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biotech Expert
    Media Profile in Sources
    Resource Type: Organization

AlterLinks


© 2021.